The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 13, 2025 for Ravi Agrawal, trustee ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ravi Agrawal, a promoter and trustee of Ravi Agrawal Trust, has released a pledge on 10,50,000 equity shares (0.84% of total share capital) of Ajanta Pharma Limited, effective November 10, 2025. The reason cited for the release is 'Excess Pledge.' After this release, the total pledged shares held under Ravi Agrawal Trust stand reduced to 60,63,920 shares (4.85% of share capital) from the earlier 71,13,920 shares (5.69%). The pledge was originally created in favour of Bajaj Finance Limited for business financing purposes.
This is a positive signal for shareholders as a reduction in pledged promoter holdings eases concerns over potential forced selling and indicates the promoter is unwinding collateral. The promoter retains significant unencumbered holdings, suggesting improved financial flexibility.